Add to ORKGA critical appraisal and clinical application of Krause DS, Simjee AE, van Rensburg C, et al. A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. Clin Infect Dis. 2004;39(6):770-775. doi: 10.1086/423378
BackgroundAlthough echinocandins have high in vitro antifungal efficacy according to prior reports, ...
Objectives: To evaluate the efficacy of anidulafungin for the treatment of candidaemia and invasive ...
Clin Microbiol Infect 2012; 18: 680-687 ABSTRACT: A prospective, multicentre, phase IIIb study with ...
(See the editorial commentary by Darouiche on pages 850–2 and the article by de Wet et al. on pages ...
(See the editorial commentary by Darouiche on pages 850–2 and the article by de Wet et al. on pages ...
The efficacy of anidulafungin, an echinocandin antifungal agent with potent anti-Candida activity, i...
AbstractCandidaemia/invasive candidiasis (C/IC) is the most frequently occurring invasive fungal inf...
AbstractCandidaemia/invasive candidiasis (C/IC) is the most frequently occurring invasive fungal inf...
Abstract Background Candida albicans is the most common cause of candidemia and other forms of invas...
Item does not contain fulltextObjectives: To evaluate the efficacy of anidulafungin for the treatmen...
AbstractA prospective, multicentre, phase Illb study with an exploratory, open-label design was cond...
Background and Purpose: Invasive candidiasis is a life-threatening condition that kills a large numb...
Diane M Cappelletty, Rose JungThe University of Toledo, College of Pharmacy, Toledo, OH, USAAbstract...
Anidulafungin is a new echinocandin with potent in vitro activity against Aspergillus and Candida sp...
Anidulafungin is a new echinocandin with potent in vitro activity against Aspergillus and Candida sp...
BackgroundAlthough echinocandins have high in vitro antifungal efficacy according to prior reports, ...
Objectives: To evaluate the efficacy of anidulafungin for the treatment of candidaemia and invasive ...
Clin Microbiol Infect 2012; 18: 680-687 ABSTRACT: A prospective, multicentre, phase IIIb study with ...
(See the editorial commentary by Darouiche on pages 850–2 and the article by de Wet et al. on pages ...
(See the editorial commentary by Darouiche on pages 850–2 and the article by de Wet et al. on pages ...
The efficacy of anidulafungin, an echinocandin antifungal agent with potent anti-Candida activity, i...
AbstractCandidaemia/invasive candidiasis (C/IC) is the most frequently occurring invasive fungal inf...
AbstractCandidaemia/invasive candidiasis (C/IC) is the most frequently occurring invasive fungal inf...
Abstract Background Candida albicans is the most common cause of candidemia and other forms of invas...
Item does not contain fulltextObjectives: To evaluate the efficacy of anidulafungin for the treatmen...
AbstractA prospective, multicentre, phase Illb study with an exploratory, open-label design was cond...
Background and Purpose: Invasive candidiasis is a life-threatening condition that kills a large numb...
Diane M Cappelletty, Rose JungThe University of Toledo, College of Pharmacy, Toledo, OH, USAAbstract...
Anidulafungin is a new echinocandin with potent in vitro activity against Aspergillus and Candida sp...
Anidulafungin is a new echinocandin with potent in vitro activity against Aspergillus and Candida sp...
BackgroundAlthough echinocandins have high in vitro antifungal efficacy according to prior reports, ...
Objectives: To evaluate the efficacy of anidulafungin for the treatment of candidaemia and invasive ...
Clin Microbiol Infect 2012; 18: 680-687 ABSTRACT: A prospective, multicentre, phase IIIb study with ...